The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data(). In process uri icon

Overview

publication date

  • June 2, 2017

Research

keywords

  • In press

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1323270

PubMed ID

  • 28573908

Additional Document Info

start page

  • 1

end page

  • 3